On July 11, 2024, Regard, an AI-powered clinical insights platform, announced the close of a $61 million Series B financing round, led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures, as well as existing investors TenOneTen Ventures, Calibrate Ventures, and Techstars. The investment will enable the company to accelerate product development with their core clinical insights platform, invest in fundamental research in large language models  (LLMs), and expand beyond inpatient facilities. Wilson Sonsini Goodrich & Rosati represented Regard in the financing.

Since its launch, Regard's technology has surfaced more than three million diagnoses to care teams and generated more than $50 million in incremental revenue for enterprise health system partners including Banner Health and Sentara. Most recently, the company announced a partnership with WakeMed Health & Hospitals, a leading health system in Raleigh, North Carolina.

The Wilson Sonsini team that advised Regard on the transaction includes Lang Liu, Annie Kim, Davelyn Couch, and Jing Zhang.

For more information, please see the press release. Further coverage can be found at TechCrunch.